Innovation Validation Call 2027

Di cosa tratta questo bando?

The call funds clinical validation, regulatory submission and market preparation for digital and AI-enabled medical devices close to market launch. It targets consortia led by a commercialising company, with up to 50% of the project budget covered.

Cosa finanzia questo bando?

Scope

The call supports innovative digital and AI-powered medical technologies that are ready for real-world clinical validation and are approaching market launch. It addresses the funding gap for solutions that need to run clinical studies, collect evidence of safety and efficacy, apply for regulatory approval and prepare for commercialisation.

Eligible solutions

Solutions are digital or AI-enabled medical devices under MDR or IVDR at Innovation Maturity Level 6 (IML 6), aiming to reach IML 7 by the end of the project, as defined in the EIT Health Healthcare Innovation Cycle Framework.

What the call funds

• Activities enabling clinical validation, such as pivotal clinical studies
• Regulatory submission, such as the CE-mark application dossier
• Product finalisation
• Market readiness and commercial strategy

Expected outcomes

Solutions must have the potential to impact 150,000 patients or citizens in the EU. They must aim to be on the market and generating at least €10,000 in revenues within three years after the funding period.

Funding conditions

The commercialising entity must sign a Financial Sustainability Contribution Agreement. If it is a micro or small enterprise, it must receive between €400,000 and €500,000 of the grant.

How to apply

Organisations register in the EU Funding & Tenders Portal to obtain a nine-digit Participant Identification Code (PIC) and then apply through the EIT Health application platform. An information session takes place on 28 October at 12:00 CET and an open Q&A session on 1 December at 15:00 CET.

Quando scade il bando?

13 January 2027, 16:00 CET. The call opens on 14 October 2026 at 11:00 CET.